Results 141 to 150 of about 8,368,252 (317)

Cell‐cycle‐specific lesion evolution rather than inhibition of double‐strand‐break repair underpins cisplatin radiosensitization

open access: yesMolecular Oncology, EarlyView.
We analyze cisplatin–DNA adducts (CDAs) and double‐strand breaks (DSBs) in a cell‐cycle‐dependent manner. We find that CDAs form similarly across all cell cycle phases. DSBs arise only in S‐phase. CDAs might not directly impair DSB repair, but S‐phase DSB lesions evolve in the presence of CDAs and disrupt repair in G2, also causing radiosensitization ...
Ye Qiu   +10 more
wiley   +1 more source

Distribución de los esfuerzos en tres tipos de elementos intrarradiculares con diferentes longitudes Stress distribution in three types of posts with different lengths

open access: yesRevista Facultad de Odontología Universidad de Antioquia, 2008
INTRODUCCIÓN: el objetivo fue observar la distribución de los esfuerzos en los dientes restaurados con elementos de retención intrarradicular (postes) de diferentes longitudes, usando el análisis de elementos finitos (AEF).
Julia Lucía Barguil Díaz   +2 more
doaj  

Interpreting the effects of DNA polymerase variants at the structural level

open access: yesMolecular Oncology, EarlyView.
Using MAVISp and molecular dynamics simulations, we analyzed over 60 000 missense variants in POLE and POLD1 from ClinVar, COSMIC, cBioPortal, and saturation mutagenesis. Identified mechanistic indicators, including stability, binding, and long‐range, enable structural interpretation, providing ACMG‐like evidence for possible reclassification of VUS ...
Matteo Arnaudi   +7 more
wiley   +1 more source

Financial and compliance audit report: State of Kansas Fiscal Year 2012

open access: yes, 2013
application/pdf; "March 2013."; "A Report to the Legislative Post Audit Committee" ...
RubinBrown, L.L.P.
core  

Proteasome inhibitor, ixazomib prevents topoisomerase‐I degradation and reverses irinotecan resistance in colorectal cancer

open access: yesMolecular Oncology, EarlyView.
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata   +10 more
wiley   +1 more source

Financial and compliance audit report: State of Kansas Fiscal Year 2011

open access: yes, 2012
"Reissued."; application/pdf; "April 2012."; "A Report to the Legislative Post Audit Committee" ...
RubinBrown, L.L.P.
core  

DNA methylation and expression of MAPRE3 affect overall survival of early‐stage non‐small cell lung cancer patients

open access: yesMolecular Oncology, EarlyView.
Both cg12821679MAPRE3 methylation and MAPRE3 expression are significantly associated with overall survival (OS) of non‐small cell lung cancer. Meanwhile, MAPRE3 expression significantly modified the effect of smoking cessation on OS. Smoking cessation benefits OS merely for patients with high MAPRE3 expression.
Chao Chen   +14 more
wiley   +1 more source

Statewide Single Audit State of Kansas ; Fiscal Year 2016

open access: yes, 2017
application/pdf; "March 2017."; "A Report to the Legislative Post Audit Committee ...
CliftonLarsonAllen, L.L.P.
core  

Circulating tumor cell viability during and after radiotherapy mirrors treatment response in cancer patients

open access: yesMolecular Oncology, EarlyView.
Radiotherapy (RT) response depends on the DNA repair capacity of tumor and host cells. We show that circulating tumor cell (CTC) counts and apoptosis rates before and after RT predict treatment response and outcome, which can be accessed via easily accessible liquid biopsy approaches. Created in BioRender. Wikman, H.
Yvonne Goy   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy